Ataxia–telangiectasia – broad implications for a rare disorder

New England Journal of Medicine

Volumn 333, Issue 10, 1995, Pages 662-664

  Kastan, Michael ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATAXIA TELANGIECTASIA; AUTOSOMAL RECESSIVE DISORDER; CANCER RISK; CEREBELLUM DEGENERATION; HUMAN; LEUKEMIA; LYMPHOMA; MOTONEURON; PRIORITY JOURNAL; SHORT SURVEY;

ATAXIA TELANGIECTASIA; HUMAN;

EID: 0029083360     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199509073331014     Document Type: Review

References (5)

1. Boder E. Ataxia-telangiectasia: an overview. In: Gatti RA, Swift M, eds. Ataxia-telangiectasia: genetics neuropathology and immunology of a degenerative disease of childhood. New York: Alan R. Liss, 1985:1-63.
2. Savitsky K, Bar-Shira A, Gilad S, A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 1995; 268: 1749-1753
3. Divecha N, Irvine RF Phospholipid signaling. Cell 1995; 80: 269-278
4. Swift M, Chase CL, Morrell D Cancer predisposition of ataxia-telangiectasia heterozygotes. Cancer Genet Cytogenet 1990; 46: 21-27
5. Swift M, Morrell D, Massey RB, Chase CL Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 1991; 325: 1831-1836